deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03787069

Intravenous Lignocaine vs Placebo

Effect of Intravenous Lignocaine vs Placebo on Hemodynamic Response During Intubation

Sponsor: Indus Hospital and Health Network

Updated 5 times since 2019 Last updated: Dec 24, 2018 Started: Dec 20, 2017 Primary completion: Jul 20, 2018 Completion: Jul 20, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hemodynamic Stability Post Intubation in Laryngoscopy Surgery, this trial is completed. The trial is conducted by Indus Hospital and Health Network and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotCompleted~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotCompleted~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Oct 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Oct 2021 [monthly]

    Completed PHASE3

  5. Jan 2019 — Jan 2021 [monthly]

    Completed PHASE3

    First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Indus Hospital and Health Network
Data source: Indus Hospital and Health Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations